Cosmax

KRX-192820
Korea Stock Exchange
Consumer Staples Household & Personal Products
Global Rank
#5750
Country Rank
#125
Market Cap
2.16 B
Price
190.15
Change (%)
2.73%
Volume
140,633

Cosmax's latest marketcap:

2.16 B

As of 06/18/2025, Cosmax's market capitalization has reached $2.16 B. According to our data, Cosmax is the 5750th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 2.16 B
Revenue (ttm) 1.61 B
Net Income (ttm) 54 M
Shares Out 11.35 M
EPS (ttm) 4.76
Forward PE 20.79
Ex-Dividend Date 12/27/2024
Earnings Date 08/12/2025
Market Cap Chart
Data Updated: 06/18/2025

Cosmax's yearly market capitalization.

Cosmax has seen its market value drop from ₩896.91 B to ₩2.16 B since 2014, representing a total decrease of 99.76% and an annual compound decline rate (CAGR) of 43.79%.
Date Market Cap Change (%) Global Rank
06/18/2025 ₩2.16 B 76.39% 5750
12/30/2024 ₩1.69 T 17.96% 8138
12/28/2023 ₩1.43 T 70.58% 8128
12/29/2022 ₩840.71 B -15.22% 10519
12/30/2021 ₩991.61 B -0.79% 10345
12/30/2020 ₩999.54 B 24.53% 8359
12/30/2019 ₩802.68 B -38.54% 8461
12/28/2018 ₩1.31 T 11.11% 5650
12/28/2017 ₩1.18 T 9.34% 6759
12/29/2016 ₩1.08 T -35.05% 7045

Company Profile

About Cosmax, Inc.

Cosmax, Inc. is a leading research, development, and manufacturing company specializing in cosmetic and health function food products. Based in Hwaseong-si, South Korea, the company operates globally, delivering innovative beauty solutions.

Business Segments

  • Cosmetic Business Segment
  • Custom Cosmetic Segment
  • Other Business Segments

Product Portfolio

Cosmax offers a diverse range of high-quality beauty and personal care products under various brands:

  • Skincare: Capsule+, IS-LCE, CeraPresso, Emulixir, Foamology, IRPT, Solar Clear
  • Base Makeup: Air Cloud, Skin Fabric
  • Makeup: Xfine, JellTeX, ARTCOTTA, Bi-Coat, Creamline, Thixolash, CRYSTAL PRISM
  • Oriental Medicine: Ginsenology
  • Fragrance: Scenteritage
  • Hair Care: Specialized formulations

Company Background

Founded in 1992 as Miroto Korea, the company rebranded to Cosmax, Inc. in 1994. Since then, it has grown into a global leader in cosmetic innovation, headquartered in Hwaseong-si, South Korea.

Frequently Asked Questions

  • What is Cosmax's (KRX-192820) current market cap?
    As of 06/18/2025, Cosmax (including the parent company, if applicable) has an estimated market capitalization of $2.16 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Cosmax global market capitalization ranking is approximately 5750 as of 06/18/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.